Autologous Bone Marrow Transplantation in Acute Nonlymphocytic Leukemia a Study of Ex Vivo Marrow Treatment with 4-Hydroperoxycyclophosphamide

  • Chapter
Minimal Residual Disease in Acute Leukemia 1986

Abstract

Current intensive chemotherapeutic regimens for the treatment of acute nonlymphocytic leukemia (ANLL) result in a substantial proportion of patients who enter prolonged first remissions and who may ultimately be cured of their leukemia (1–3). However, patients who experience hematologic relapses of ANLL have an extremely poor prognosis and a minimal chance for leukemia-free survival. Allogeneic bone marrow transplantation (BMT) in such patients provides an opportunity for cure, although the risks of graft-versus-host disease (GVHD) and opportunistic infections, notably viral interstitial pneumonitis, account for most of the mortality after allogeneic BMT (4–7). Furthermore, 60–75% of patients who are otherwise suitable allogeneic BMT candidates lack related MHC-matched donors, and allogeneic BMT is generally not feasible in patients over 40 years of age because of the high mortality associated with transplant-related complications (7–9).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
EUR 29.95
Price includes VAT (Germany)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
EUR 160.49
Price includes VAT (Germany)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
EUR 213.99
Price includes VAT (Germany)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info
Hardcover Book
EUR 213.99
Price includes VAT (Germany)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Vaughan WP, Karp JE, Burke PJ (1984): Two-cycle timed-sequential chemotherapy for adult acute nonlymphocytic leukemia. Blood 64: 975–980.

    PubMed  CAS  Google Scholar 

  2. Weinstein HJ, Mayer RJ, Rosenthal DS, et al. (1983): Chemotherapy for acute myelogenous leukemia in children and adults: VAPA update. Blood 62: 315–319.

    PubMed  CAS  Google Scholar 

  3. Wolff SN, Marion J, Stein RS, et al. (1984): High-dose (HD) cytosine arabinoside (Ara-C) and daunorubicin (D) for acute non-lymphocytic leukemia (ANLL) in first remission. Proc ASCO 3: 193 (Abstract).

    Google Scholar 

  4. O’Reilly RJ (1983): Allogeneic bone marrow transplantation: Current status and future directions. Blood 62: 941–964.

    PubMed  Google Scholar 

  5. Meyers JD, Flournoy N, Thomas ED (1982): Nonbacterial pneumonia after allogeneic marrow transplantation: A review of ten years’ experience. J Inf Dis 4: 1119–1132.

    Article  CAS  Google Scholar 

  6. Santos GW (1984): Bone marrow transplantation in leukemia: Current status. Cancer 54: 2732–2740.

    Article  PubMed  CAS  Google Scholar 

  7. Santos GW, Tutschka PJ, Brookmeyer R, et al. (1983): Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide. N Engl J Med 309: 1347–1353.

    Article  PubMed  CAS  Google Scholar 

  8. Thomas ED, Buckner CD, Clift RA, et al. (1979): Marrow transplantation for acute nonlymphoblastic leukemia in first remission. N Engl J Med 301: 597–599.

    Article  PubMed  CAS  Google Scholar 

  9. Thomas ED, Clift RA, Buckner CD (1982): Marrow transplantation for patients with acute nonlymphoblastic leukemia who achieve a first remission. Cancer Treat Rep 66: 1463–1466.

    PubMed  CAS  Google Scholar 

  10. Sharkis SJ, Santos GW, Colvin OM (1980): Elimination of acute myelogenous leukemia cells from marrow and tumor suspensions in the rat with 4-hydroperoxycyclophosphamide. Blood 55: 521–523.

    PubMed  CAS  Google Scholar 

  11. Takamizawa A, Matsumoto S, Iwata T, et al. (1973): Studies on cyclophosphamide metabolites and their related compounds. II. Preparation of an active species of cyclophosphamide and some related compounds. J Am Chem Soc 95: 985–986.

    Article  CAS  Google Scholar 

  12. Kaizer H, Stuart RK, Brookmeyer R, et al. (1985): Autologous bone marrow transplantation in acute leukemia: A phase I study of in vitro treatment of marrow with 4-hydroperoxycyclophosphamide to purge tumor cells. Blood 65: 1504–1510.

    PubMed  CAS  Google Scholar 

  13. Thomas ED, Storb R (1970): Technique for human marrow grafting. Blood 36: 507–515.

    PubMed  CAS  Google Scholar 

  14. Santos GW, Bias WB, Beschorner WE, et al. (1983): Allogeneic and syngeneic marrow transplantation for acute lymphocytic leukemia (ALL) in remission — Baltimore experience. Exp Hematol 11 (Suppl 14): 132 (Abstract).

    Google Scholar 

  15. Hickman RO, Buckner CD, Clift RA, et al. (1979): A modified right atrial catheter for access to the venous system in marrow transplant recipients. Surg Gynecol Obstet 148: 871–875.

    PubMed  CAS  Google Scholar 

  16. Saral R, Burns WH, Laskin OL, et al. (1981): Acyclovir prophylaxis of herpes simplex virus infections: A randomized double-blind controlled trial in bone marrow transplant recipients. N Engl J Med 305: 63–67.

    Article  PubMed  CAS  Google Scholar 

  17. Kaplan EM, Meier P (1958): Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457–481.

    Article  Google Scholar 

  18. Fefer A, Cheever MA, Greenberg PD, et al. (1983): Bone marrow transplantation (BMT) with identical twins: Improved results with BMT in complete remission (CR). Proc ASCO 2: 182 (Abstract).

    Google Scholar 

  19. Weiden PL, Flournoy N, Thomas ED, et al. (1979): Antileukemic effect of graft-versus-host disease in human recipients of allogeneic marrow grafts. N Engl J Med 300: 1068–1073.

    Article  PubMed  CAS  Google Scholar 

  20. Weiden PL, Sullivan KM, Flournoy N, et al. (1981): Antileukemic effect of chronic graft-versus-host disease: Contribution to improved survival after allogeneic marrow transplantation. N Engl J Med 304: 1529–1532.

    Article  PubMed  CAS  Google Scholar 

  21. Dicke KA, Zander A, Spitzer G, et al. (1978): Autologous bone marrow transplantation in relapsed adult leukemia. Lancet 1: 1514–1517.

    Google Scholar 

  22. Feeney M, Knapp RC, Greenberger JS, et al. (1981): Elimination of leukemic cells from rat bone marrow using antibody and complement. Cancer Res 41: 3331–3335.

    PubMed  CAS  Google Scholar 

  23. Bast RC Jr, Ritz J, Lipton JM, et al. (1983): Elimination of leukemic cells from human bone marrow using monoclonal antibody and complement. Cancer Res 43: 1389–1394.

    PubMed  Google Scholar 

  24. Uckun FM, Ramakrishnan S, Houston LL (1985): Immunotoxin-mediated elimination of clonogenic tumor cells in the presence of human bone marrow. J Immunol 134: 2010–2016.

    PubMed  CAS  Google Scholar 

  25. Ramsay N, LeBien T, Nesbit M, et al. (1985): Autologous bone marrow transplantation for patients with acute lymphoblastic leukemia in second or subsequent remission: Results of bone marrow treated with monoclonal antibodies BA-1, BA-2, and BA-3 plus complement. Blood 66: 508–513.

    PubMed  CAS  Google Scholar 

  26. Anderson KC, Sallan S, Takvorian T, et al. (1985): Monoclonal antibody (MA) purged autologous bone marrow transplantation (ABMT) for relapsed non-T acute lymphoblastic leukemia (ALL). Int J Cell Cloning 3: 239–240 (Abstract).

    Google Scholar 

  27. Gorin NC, Douay L, Laporte JP, et al. (1985): Autologous bone marrow transplantation using marrow incubated with ASTA-Z-7557 in adult acute leukemia. Int J Cell Cloning 3: 249–250 (Abstract).

    Google Scholar 

  28. Herve P, Cahn JY, Flesch M, et al. (1985): Autologous bone marrow transplantation (ABMT) for acute leukemia in remission. Int J Cell Cloning 3: 242–243 (Abstract).

    Google Scholar 

  29. Rowley SD, Colvin OM, Stuart RK (1985): Human multilineage progenitor cell sensitivity to 4-hydroperoxycyclophosphamide. Exp Hematol 13: 295–297.

    PubMed  CAS  Google Scholar 

  30. Burnett AK, Tansey P, Alcorn M, et al. (1984): Autologous bone marrow transplantation in first remission of acute myelogenous leukemia. Exp Hematol 12 (Suppl 15): 126–127.

    Google Scholar 

  31. Burnett AK, Tansey P, Watkins R, et al. (1984): Transplantation of unpurged autologous bone-marrow in acute myeloid leukemia in first remission. Lancet 2: 1068–1070.

    Article  PubMed  CAS  Google Scholar 

  32. Gorin NC (1984): Autologous bone marrow transplantation for acute leukemia in Europe. Exp Hematol 12 (Suppl 15): 123–125.

    Google Scholar 

  33. Laporte JP, Gorin NC, Douay L, et al. (1984): Autologous bone marrow transplantation (ABMT) with marrow purged by ASTA Z-7557, as consolidation therapy for acute leukemias in first remission. Exp Hematol 12 (Suppl 15): 132.

    Google Scholar 

  34. Nerve P, Cahn JY, Plouvier E, et al. (1984): Autologous bone marrow transplantation in acute leukemia using marrow cells chemopurified with a cyclophosphamide derivative (ASTA Z 7557): Clinical results. Exp Hematol 12 (Suppl 15): 133–134.

    Google Scholar 

  35. Appelbaum FR, Meyers JD, Fefer A, et al. (1982): Nonbacterial nonfungal pneumonia following marrow transplantation in 100 identical twins. Transplantation 33: 265–268.

    Article  Google Scholar 

  36. Lowenberg B, Abels J, van Bekkum DW, et al. (1984): Transplantation of non-purified autologous bone marrow in patients with AML in first remission. Cancer 54: 2840–2843.

    Article  PubMed  CAS  Google Scholar 

  37. Stewart P, Buckner CD, Bensinger W, et al. (1985): Autologous marrow transplantation in patients with acute nonlymphocytic leukemia in first remission. Exp Hematol 13: 267–272.

    PubMed  CAS  Google Scholar 

  38. Champlin RE, Ho WG, Gale RP, et al. (1985): Treatment of acute myelogenous leukemia: A prospective controlled trial of bone marrow transplantation versus consolidation chemotherapy. Ann Int Med 102: 285–291.

    PubMed  CAS  Google Scholar 

  39. Appelbaum FR, Dahlberg S, Thomas ED, et al. (1984): Bone marrow transplantation or chemotherapy after remission induction for adults with acute nonlymphoblastic leukemia: A prospective comparison. Ann Int Med 101: 581–588.

    PubMed  CAS  Google Scholar 

  40. Dicke KA, Jagannath S, Vellekoop L, et al. (1985): Results of autologous bone marrow transplantation in second and subsequent remissions in acute leukemia. Int J Cell Cloning 3: 240 (Abstract).

    Google Scholar 

  41. Bortin MM, Buckner CD (1983): Major complications of marrow harvesting for transplantation. Exp Hematol 11: 916–921.

    PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Martinus Nijhoff Publishers, Dordrecht

About this chapter

Cite this chapter

Yeager, A.M. et al. (1986). Autologous Bone Marrow Transplantation in Acute Nonlymphocytic Leukemia a Study of Ex Vivo Marrow Treatment with 4-Hydroperoxycyclophosphamide. In: Hagenbeek, A., Löwenberg, B. (eds) Minimal Residual Disease in Acute Leukemia 1986. Developments in Oncology, vol 45. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-4273-8_22

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-4273-8_22

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-8398-0

  • Online ISBN: 978-94-009-4273-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Navigation